Unitaid welcomes World Tuberculosis Day 2021 with record-level investments in innovative solutions that bring substantive contribution to ending tuberculosis and saving lives.

Every year, nearly 1.5 million die from TB and 10 million people fall ill with the disease. The COVID-19 pandemic has intensified existing access challenges to efficient prevention, diagnosis and care threatening to reverse the gains made over recent years.

Ensuring wider access to better, simpler and more affordable solutions to stop the spread of tuberculosis (TB) has always been at the core of Unitaid’s mission. It is now more important than ever to redouble our efforts when it comes to TB.

“In these exceptional times, innovation has proven to be even more critical than ever to tackle tuberculosis. We need to redouble our efforts across prevention, diagnosis and treatment to ensure that affordable, simpler and adapted solutions are made available in low- and middle-income countries, particularly for the people who need them the most” said Dr Philippe Duneton, Unitaid Executive Director.

Our recent releases:

• Unitaid reaffirms its commitment to combat tuberculosis in times of COVID-19
• Call for proposal: Unitaid looks to invest in better tools to improve tuberculosis detection
• New patient-friendly tuberculosis preventive treatment to be rolled out in five high-burden TB countries at affordable price
• Unitaid ranked as one of the world’s leaders in funding tuberculosis research

Unitaid’s work in TB:

• Unitaid-funded TB projects (Web site)
• Unitaid and tuberculosis  (Factsheet)
• Unitaid TB portfolio (Infographic)
• Shaping a better future for children exposed to MDR-TB (Web story)
• How digital technologies can empower patients to succeed in TB treatment (Web story)
• Improving use of tuberculosis diagnostics (Impact story)
• Childhood tuberculosis (Impact story)
• Expanding access to next generation drug-resistant tuberculosis treatment (Impact story)